Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients

about

Factor V Leiden 1691G/A and prothrombin gene 20210G/A polymorphisms as prothrombotic markers in adult Egyptian acute leukemia patients.

P2860

Q38985825-6F7C1680-7AF4-4FBC-BC98-D22B4EF7435C

P2860

Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients

Item

http://www.wikidata.org/entity/Q42352047

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Factor V Leiden and Prothrombi ...... sh Pediatric Leukemia Patients

@en

Factor V Leiden and Prothrombi ...... sh Pediatric Leukemia Patients

@nl

type

Item

label

Factor V Leiden and Prothrombi ...... sh Pediatric Leukemia Patients

@en

Factor V Leiden and Prothrombi ...... sh Pediatric Leukemia Patients

@nl

prefLabel

Factor V Leiden and Prothrombi ...... sh Pediatric Leukemia Patients

@en

Factor V Leiden and Prothrombi ...... sh Pediatric Leukemia Patients

@nl

P1476

Factor V Leiden and Prothrombi ...... sh Pediatric Leukemia Patients

@en

P2093

Dilara Fatma Akın

http://www.w3.org/2001/XMLSchema#string

Emin Kürekçi

http://www.w3.org/2001/XMLSchema#string

Kadir Sipahi

http://www.w3.org/2001/XMLSchema#string

Nejat Akar

http://www.w3.org/2001/XMLSchema#string

Serpil Taşdelen

http://www.w3.org/2001/XMLSchema#string

Tuğba Kayaalp

http://www.w3.org/2001/XMLSchema#string

Yonca Eğin

http://www.w3.org/2001/XMLSchema#string

P2860

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

Molecular basis for the relationship between thrombosis and cancer.

Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.

Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia.

Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment.

Factor V 1691 G-A mutation distribution in a healthy Turkish population.

Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients.

Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.

Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.

P304

250432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/250432

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

Ustun Ezer

P577

2012-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233806833

http://www.w3.org/2001/XMLSchema#string

P698

23198154

http://www.w3.org/2001/XMLSchema#string

P932

3505918

http://www.w3.org/2001/XMLSchema#string

Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients

about

P2860

P2860

Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932